The EPCOT International Flower & Garden Festival is celebrating its 30th anniversary. The festival features numerous ...

A few standouts: Chicken and waffles at The Honey Bee-stro, near Port of Entry at World ... At Lan Yuan in China, the Satay Beef Bao Bun with pan-fried beef, red onion and jalapeño in Chinese ...

Sutro Biopharma Inc (NASDAQ:STRO) has prioritized three wholly owned pre-clinical programs in its next-generation ADC pipeline, indicating a focused strategic direction. The company's cash runway ...

We're basically making a one-pot meal with rice, beans, peppers, scallions, beef, cheese, stuffing all of that into a tortilla, rolling it up, then adding crispy cheese to the outside by melting ...

Sutro Biopharma (NASDAQ:STRO) fell ~14% in the premarket on Friday after the company announced its decision to deprioritize its studies into the antibody-drug conjugate luveltamab tazevibulin as ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Sutro Biopharma (STRO – Research Report). The company’s shares closed yesterday at $1.25.

Sutro Biopharma (NASDAQ:STRO) said on Thursday that, under its portfolio review, the company has decided to advance its dual-payload ADC programs, while deprioritizing development of luveltamab ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sutro Biopharma (STRO – Research Report) and Generation Bio (GBIO – Research Report).

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to earnings of $0.42 per share a year ago.